Lee Hannah S W, Boulton Ian C, Reddin Karen, Wong Henry, Halliwell Denise, Mandelboim Ofer, Gorringe Andrew R, Gray-Owen Scott D
Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Infect Immun. 2007 Sep;75(9):4449-55. doi: 10.1128/IAI.00222-07. Epub 2007 Jul 9.
Pathogenic Neisseria bacteria naturally liberate outer membrane "blebs," which are presumed to contribute to pathology, and the detergent-extracted outer membrane vesicles (OMVs) from Neisseria meningitidis are currently employed as meningococcal vaccines in humans. While the composition of these vesicles reflects the bacteria from which they are derived, the functions of many of their constituent proteins remain unexplored. The neisserial colony opacity-associated Opa proteins function as adhesins, the majority of which mediate bacterial attachment to human carcinoembryonic antigen-related cellular adhesion molecules (CEACAMs). Herein, we demonstrate that the Opa proteins within OMV preparations retain the capacity to bind the immunoreceptor tyrosine-based inhibitory motif-containing coinhibitory receptor CEACAM1. When CD4(+) T lymphocytes were exposed to OMVs from Opa-expressing bacteria, their activation and proliferation in response to a variety of stimuli were effectively halted. This potent immunosuppressive effect suggests that localized infection will generate a "zone of inhibition" resulting from the diffusion of membrane blebs into the surrounding tissues. Moreover, it demonstrates that OMV-based vaccines must be developed from strains that lack CEACAM1-binding Opa variants.
致病性奈瑟菌会自然释放外膜“泡状物”,据推测这些泡状物会导致病变,目前脑膜炎奈瑟菌经去污剂提取的外膜囊泡(OMV)被用作人类的脑膜炎球菌疫苗。虽然这些囊泡的组成反映了其来源的细菌,但许多组成蛋白的功能仍未得到探索。奈瑟菌菌落不透明相关的Opa蛋白作为黏附素发挥作用,其中大多数介导细菌与人癌胚抗原相关细胞黏附分子(CEACAM)的结合。在此,我们证明OMV制剂中的Opa蛋白保留了与含免疫受体酪氨酸抑制基序的共抑制受体CEACAM1结合的能力。当CD4(+) T淋巴细胞暴露于来自表达Opa的细菌的OMV时,它们对各种刺激的激活和增殖被有效抑制。这种强大的免疫抑制作用表明,局部感染会因膜泡扩散到周围组织而产生“抑制区”。此外,这表明基于OMV的疫苗必须从缺乏与CEACAM1结合的Opa变体的菌株中开发。